We are live on ! Find out more
MAM

Meeder Asset Management Portfolio holdings

AUM $1.75B
1-Year Est. Return 34.85%
This Fund
S&P 500
This Quarter Est. Return
-0.02%
1 Year Est. Return
+34.85%
3 Year Est. Return
+121.24%
5 Year Est. Return
+152.15%
10 Year Est. Return
+544.68%
AUM
$1.08B
AUM Growth
-$99.6M
Cap. Flow
-$85.6M
Cap. Flow %
-7.95%
Top 10 Hldgs %
22.85%
Holding
1,895
New
210
Increased
564
Reduced
645
Closed
335

Sector Composition

Rank Sector Weight
1 Financials 15.39%
2 Technology 13.91%
3 Healthcare 10.79%
4 Consumer Discretionary 8.13%
5 Industrials 7.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVLN
1426
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$2K ﹤0.01%
664
-100
-13% -$424
MBTF
1427
DELISTED
MBT Financial Corporation
MBTF
$2K ﹤0.01%
+154
New +$1.61K
CTRL
1428
DELISTED
Control4 Corporation
CTRL
$2K ﹤0.01%
76
-1,566
-95% -$41.9K
CLD
1429
DELISTED
Cloud Peak Energy Inc
CLD
$2K ﹤0.01%
756
+269
+55% +$1.11K
OCLR
1430
DELISTED
Oclaro Inc.
OCLR
$2K ﹤0.01%
228
-694
-75% -$5.21K
DHCP
1431
DELISTED
Ditech Holding Corporation
DHCP
$2K ﹤0.01%
+181
New +$1.83K
FFKT
1432
DELISTED
Farmers Capital Bank Corp
FFKT
$2K ﹤0.01%
56
KND
1433
DELISTED
Kindred Healthcare
KND
$2K ﹤0.01%
244
+23
+10% +$213
FINL
1434
DELISTED
Finish Line
FINL
$2K ﹤0.01%
115
-596
-84% -$6.87K
WG
1435
DELISTED
Willbros Group
WG
$2K ﹤0.01%
4,061
+1,115
+38% +$1.11K
REGI
1436
DELISTED
Renewable Energy Group, Inc.
REGI
$2K ﹤0.01%
127
-219
-63% -$2.46K
NIHD
1437
DELISTED
NII Holdings, Inc. Common Stock
NIHD
$2K ﹤0.01%
799
-4,253
-84% -$4.41K
AKBA icon
1438
Akebia Therapeutics
AKBA
$250M
$1K ﹤0.01%
80
-140
-64% -$1.96K
ANF icon
1439
Abercrombie & Fitch
ANF
$4.95B
$1K ﹤0.01%
47
+43
+1,075% +$908
AQMS icon
1440
Aqua Metals
AQMS
$9.6M
$1K ﹤0.01%
3
AZTA icon
1441
Azenta
AZTA
$1.43B
$1K ﹤0.01%
36
-388
-92% -$10.6K
CLDX icon
1442
Celldex Therapeutics
CLDX
$3.23B
$1K ﹤0.01%
38
+14
+58% +$542
COLL icon
1443
Collegium Pharmaceutical
COLL
$962M
$1K ﹤0.01%
52
+2
+4% +$48
COOP
1444
DELISTED
Mr. Cooper
COOP
$1K ﹤0.01%
86
-14
-14% -$192
CRIS icon
1445
Curis
CRIS
$8.5M
$1K ﹤0.01%
1
CRVS icon
1446
Corvus Pharmaceuticals
CRVS
$1.16B
$1K ﹤0.01%
108
+10
+10% +$95
DAKT icon
1447
Daktronics
DAKT
$1.05B
$1K ﹤0.01%
110
DRI icon
1448
Darden Restaurants
DRI
$24B
$1K ﹤0.01%
8
-10,604
-100% -$1M
DX
1449
Dynex Capital
DX
$3.18B
$1K ﹤0.01%
47
-5,125
-99% -$100K
XRN
1450
Chiron Real Estate Inc
XRN
$466M
$1K ﹤0.01%
25
+4
+19% +$149

Similar funds

Meeder Asset Management's Q1 2018 Portfolio in Review

As of Q1 2018, Meeder Asset Management held 1,895 positions worth $1.08B, down 8.5% from $1.18B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Meeder Asset Management withdrew a net $85.6M in Q1 2018, closing 335 positions and reducing 645 holdings. Its most notable exit was Prologis, an estimated $4.69M position sold in full.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 13% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Meeder Asset Management opened a new position in Vanguard Intermediate-Term Corporate Bond ETF worth $30M.

  • Meeder Asset Management's largest Q1 2018 buy was Vanguard Intermediate-Term Corporate Bond ETF: 354,159 shares worth $30M.
  • Meeder Asset Management added most to Vanguard Total Bond Market in Q1 2018, an estimated $11.6M increase.
  • Meeder Asset Management's biggest Q1 2018 reduction was iShares 7-10 Year Treasury Bond ETF, cutting an estimated $51.6M.
  • Meeder Asset Management fully exited Prologis in Q1 2018, selling an estimated $4.69M.
  • Meeder Asset Management's ten largest holdings make up 23% of its $1.08B portfolio in Q1 2018.
  • Meeder Asset Management opened 210 new positions and closed 335 in Q1 2018.
  • Meeder Asset Management's portfolio value fell 8.5% quarter-over-quarter to $1.08B.

Based on Meeder Asset Management's 13F filing for Q1 2018, filed 3 May 2018.